Straker, Richard J. III http://orcid.org/0000-0002-2263-3576
Song, Yun
Sun, James
Shannon, Adrienne B.
Cohen, Leah S.
Muradova, Elnara
Daou, Hala
Krause, Kate
Li, Siming
Frederick, Dennie T.
Rhodin, Kristen E.
Brizel, David M.
Boland, Genevieve M.
Beasley, Georgia M.
Wuthrick, Evan J.
Sondak, Vernon K.
Zager, Jonathan S.
Lin, Alexander
Lukens, John N.
Karakousis, Giorgos C.
Article History
Received: 21 September 2020
Accepted: 20 October 2020
First Online: 23 November 2020
Disclosure
: Dr. Sondak reports personal fees from Array, Bristol Myers Squibb, Genentech, Merck, Novartis, Pfizer, Regeneron, and Replimune, outside the submitted work. Dr. Wuthrick reports personal fees from Varian and Sanofi, outside the submitted work. Dr. Zager reports advisory board participation with Merck, Amgen, and Sanofi Regeneron; speakers bureau participation with Array Biopharma and Sun Pharma; and research work with Amgen, Provectus, Castle Biosciences, and Delcath Systems, all outside the submitted work. Dr. Boland has sponsored research agreements with Palleon Pharmaceuticals and Olink Proteomics. She served on scientific advisory boards for Nektar Therapeutics and Novartis. She has received honoraria from Novartis and Takeda Pharmaceutics. She served as a consultant to Northwest Biotherapeutics. Dr. Georgia Beasley reports relevant financial activities outside the submitted work as a member of the 2020 Regeneron Sanofi advisory board. Other authors declare no conflicts of interest.
: All authors have reviewed and approved the submitted manuscript.